Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Clinical trial NCT07228403 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07228403
- Sponsor
- Zealand Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-11
- Primary completion
- 2028-09-18
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.